Skip to main content

View full-text article in PMC

. 2022 Dec 23;10(2):1066–1076. doi: 10.1002/ehf2.14268

Table 5.

Change in Kansas City cardiomyopathy questionnaire from baseline to 3 months

	Group	Baseline		3 month change from baseline
	Group	n	Mean (SD)	n	Mean (SD)	Difference in means	95% CI
Overall summary score	SZC	90	57.69 (20.00)	53	9.94 (14.62)	5.20	(−0.17, 10.57)
Overall summary score	Placebo	87	60.78 (21.10)	47	4.74 (12.12)
Total symptom score	SZC	90	61.21 (23.31)	53	10.36 (16.84)	3.28	(−3.59, 10.15)
Total symptom score	Placebo	87	63.68 (23.11)	47	7.08 (17.77)
Clinical summary score	SZC	90	57.56 (21.66)	53	9.54 (14.13)	6.04	(0.21, 11.88)
Clinical summary score	Placebo	87	62.72 (21.93)	47	3.50 (15.27)

Abbreviation: CI, confidence interval.